Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 644

1.

Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.

Yonkers KA, Pearlstein T, Fayyad R, Gillespie JA.

J Affect Disord. 2005 Apr;85(3):317-21.

PMID:
15780701
[PubMed - indexed for MEDLINE]
2.

Pretreatment pattern of symptom expression in premenstrual dysphoric disorder.

Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA.

J Affect Disord. 2005 Apr;85(3):275-82.

PMID:
15780697
[PubMed - indexed for MEDLINE]
3.

Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.

Miner C, Brown E, McCray S, Gonzales J, Wohlreich M.

Clin Ther. 2002 Mar;24(3):417-33.

PMID:
11952025
[PubMed - indexed for MEDLINE]
4.

Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder.

Cohen LS, Soares CN, Lyster A, Cassano P, Brandes M, Leblanc GA.

J Clin Psychopharmacol. 2004 Oct;24(5):540-3.

PMID:
15349012
[PubMed - indexed for MEDLINE]
5.

Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder.

Halbreich U, Bergeron R, Yonkers KA, Freeman E, Stout AL, Cohen L.

Obstet Gynecol. 2002 Dec;100(6):1219-29.

PMID:
12468166
[PubMed - indexed for MEDLINE]
6.

Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.

Freeman EW, Rickels K, Sondheimer SJ, Polansky M, Xiao S.

Am J Psychiatry. 2004 Feb;161(2):343-51.

PMID:
14754784
[PubMed - indexed for MEDLINE]
7.

Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.

Halbreich U, Smoller JW.

J Clin Psychiatry. 1997 Sep;58(9):399-402.

PMID:
9378691
[PubMed - indexed for MEDLINE]
8.

Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.

Kornstein SG, Pearlstein TB, Fayyad R, Farfel GM, Gillespie JA.

J Clin Psychiatry. 2006 Oct;67(10):1624-32.

PMID:
17107257
[PubMed - indexed for MEDLINE]
9.

A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder.

Freeman EW, Sondheimer SJ, Sammel MD, Ferdousi T, Lin H.

J Clin Psychiatry. 2005 Jun;66(6):769-73.

PMID:
15960573
[PubMed - indexed for MEDLINE]
10.

Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial.

Young SA, Hurt PH, Benedek DM, Howard RS.

J Clin Psychiatry. 1998 Feb;59(2):76-80.

PMID:
9501889
[PubMed - indexed for MEDLINE]
11.

Variable dosing of sertraline for premenstrual exacerbation of depression: a pilot study.

Miller MN, Newell CL, Miller BE, Frizzell PG, Kayser RA, Ferslew KE.

J Womens Health (Larchmt). 2008 Jul-Aug;17(6):993-7. doi: 10.1089/jwh.2007.0491.

PMID:
18681820
[PubMed - indexed for MEDLINE]
12.

Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.

Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA.

J Clin Psychiatry. 2000 Feb;61(2):101-9.

PMID:
10732657
[PubMed - indexed for MEDLINE]
13.

Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.

Jermain DM, Preece CK, Sykes RL, Kuehl TJ, Sulak PJ.

Arch Fam Med. 1999 Jul-Aug;8(4):328-32.

PMID:
10418540
[PubMed - indexed for MEDLINE]
14.

Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline.

Halbreich U, Kahn LS.

Expert Opin Pharmacother. 2003 Nov;4(11):2065-78. Review.

PMID:
14596660
[PubMed - indexed for MEDLINE]
15.

Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.

Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, McCray S.

Obstet Gynecol. 2002 Sep;100(3):435-44.

PMID:
12220761
[PubMed - indexed for MEDLINE]
16.

Predictors of response to sertraline treatment of severe premenstrual syndromes.

Freeman EW, Sondheimer SJ, Polansky M, Garcia-Espagna B.

J Clin Psychiatry. 2000 Aug;61(8):579-84.

PMID:
10982201
[PubMed - indexed for MEDLINE]
17.

Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment.

Pearlstein T, Joliat MJ, Brown EB, Miner CM.

Am J Obstet Gynecol. 2003 Apr;188(4):887-95.

PMID:
12712081
[PubMed - indexed for MEDLINE]
18.

Intermittent versus continuous sertraline therapy in the treatment of premenstrual dysphoric disorders.

Alpay FB, Turhan NO.

Int J Fertil Womens Med. 2001 Jul-Aug;46(4):228-31.

PMID:
11563834
[PubMed - indexed for MEDLINE]
19.

Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.

Freeman EW.

CNS Drugs. 2004;18(7):453-68. Review.

PMID:
15139800
[PubMed - indexed for MEDLINE]
20.

Citalopram in PMS patients with prior SSRI treatment failure: a preliminary study.

Freeman EW, Jabara S, Sondheimer SJ, Auletto R.

J Womens Health Gend Based Med. 2002 Jun;11(5):459-64.

PMID:
12165163
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk